Viewing Study NCT07009457


Ignite Creation Date: 2025-12-24 @ 6:38 PM
Ignite Modification Date: 2026-01-04 @ 11:25 PM
Study NCT ID: NCT07009457
Status: RECRUITING
Last Update Posted: 2025-07-04
First Post: 2025-05-29
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Phase I Clinical Study of SHR-1316 (SC) Combined With Carboplatin and Etoposide as First-line Treatment for Extensive Stage Small Cell Lung Cancer
Sponsor: Suzhou Suncadia Biopharmaceuticals Co., Ltd.
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module